UNSPSC 51273007: Phencyclidine

This classification denotes an anesthetic agent with the molecular formula C17H25N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J1DOI7UV76, chemically known as piperidine, 1- (1-phenylcyclohexyl)-, hydrochloride but generally known as phencyclidine, which bears US NIH Compound Identifier 6468. European Medicines Agency schedules Phencyclidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09755MIG.

UNSPSC 51273007 Phencyclidine, a Commodity code, shows minimal recent state and local procurement activity directly aligned with its nominal scope. The three recent opportunities on record—a naloxone and drug deactivation systems IFB from Seminole County, Florida; a therapeutic pharmacy initiative RFI from Texas Health and Human Services Commission; and a generic multi-source pharmaceuticals RFP from the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP)—do not target phencyclidine specifically. Naloxone and generic pharmaceuticals procurement fall under distinct UNSPSC classifications and represent emergency medical supply and general pharmacy benefit management rather than the controlled substance this code nominally describes. The mismatch between code assignment and actual solicitation scope suggests either miscoding in the state and local procurement systems or that phencyclidine itself does not see routine procurement activity through state and local channels.

The geographic spread of the three opportunities spans Florida, Texas, and a multi-state cooperative centered in Minnesota, but none targets the commodity named in the code. Seminole County's IFB (due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries. The Texas HHS Commission's RFI (response deadline April 3, 2026) explored direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. MMCAP's RFP (due March 26, 2026) solicited generic pharmaceuticals and OTC products for multi-state distribution through authorized wholesalers including Cencora and Cardinal Health. State and local governments do not appear to be procuring phencyclidine as a commodity through standard solicitation mechanisms. This code warrants low pursuit priority unless your firm has a specific role in pharmaceutical supply chain infrastructure or law enforcement evidence control that the recent opportunity record does not reflect.